Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 50

Vaccine

Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDル
COVID-19 | Life Science History | Vaccine

Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDル

On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…

Read More Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDルContinue

Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19

On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…

Read More Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19Continue

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
COVID-19 | Life Science History | NIH | Vaccine

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths

On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…

Read More Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deathsContinue

Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
Biotechnology | Life Science History | Vaccine

Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection

On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…

Read More Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infectionContinue

Moderna and ROVI announced collaboration for OUS fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Moderna and ROVI announced collaboration for OUS fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate

On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…

Read More Moderna and ROVI announced collaboration for OUS fill-finish manufacturing of Moderna’s COVID-19 vaccine candidateContinue

Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVIDル
COVID-19 | Life Science History | Vaccine

Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVIDル

On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…

Read More Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVIDルContinue

Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteers
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteers

On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…

Read More Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteersContinue

Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)

On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…

Read More Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)Continue

BD partnered with U.S. Government on $70 million manufacturing infrastructure project for mass vaccination campaigns
Biotechnology | COVID-19 | Infectious Disease | Medical Device | Vaccine

BD partnered with U.S. Government on $70 million manufacturing infrastructure project for mass vaccination campaigns

On Jul. 8, 2020, BD (Becton, Dickinson) announced the formation of a strategic, public-private partnership with the Biomedical…

Read More BD partnered with U.S. Government on $70 million manufacturing infrastructure project for mass vaccination campaignsContinue

First adjuvanted quadrivalent influenza vaccine received EU approval
Biotechnology | Infectious Disease | Influenza | Vaccine

First adjuvanted quadrivalent influenza vaccine received EU approval

On Jul. 8, 2020, the European Commission announced regulatory approval for the first adjuvanted quadrivalent influenza vaccine to…

Read More First adjuvanted quadrivalent influenza vaccine received EU approvalContinue

Fred Hutch joined international COVID-19 vaccine effort
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Fred Hutch joined international COVID-19 vaccine effort

On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…

Read More Fred Hutch joined international COVID-19 vaccine effortContinue

GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
COVID-19 | Life Science History | Vaccine

GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…

Read More GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccineContinue

Novavax announced $1.6 billion funding from Operation Warp Speed
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax announced $1.6 billion funding from Operation Warp Speed

On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…

Read More Novavax announced $1.6 billion funding from Operation Warp SpeedContinue

Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics

On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…

Read More Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeuticsContinue

European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing
COVID-19 | Disease | Vaccine

European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing

On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…

Read More European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturingContinue

Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
COVID-19 | Life Science History | Vaccine

Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial

On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…

Read More Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trialContinue

Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
COVID-19 | Life Science History | Vaccine

Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials

On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…

Read More Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trialsContinue

Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonメs COVID-19 vaccine candidate
Life Science History | Vaccine

Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonメs COVID-19 vaccine candidate

On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…

Read More Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonメs COVID-19 vaccine candidateContinue

CDC announced action to prepare against ‘G4’ swine flu viruses in China with pandemic potential
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Vaccine

CDC announced action to prepare against ‘G4’ swine flu viruses in China with pandemic potential

On Jul. 2, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced a publication in the…

Read More CDC announced action to prepare against ‘G4’ swine flu viruses in China with pandemic potentialContinue

UConn-made COVID-19 custom mask solution to be manufactured
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

UConn-made COVID-19 custom mask solution to be manufactured

On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…

Read More UConn-made COVID-19 custom mask solution to be manufacturedContinue

Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio
Biotechnology | Therapeutics | Vaccine

Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio

On Jul. 1, 2020, Intravacc announced the signing of a strategic partnership agreement with Dutch based CimCure, focusing…

Read More Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolioContinue

NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
COVID-19 | Life Science History | NIH | Vaccine

NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development

On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHメs…

Read More NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine developmentContinue

Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
Life Science History | Vaccine

Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2

On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…

Read More Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2Continue

Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShield single dose intranasal anthrax vaccine candidate
Biotechnology | Infectious Disease | Vaccine

Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShield single dose intranasal anthrax vaccine candidate

On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Company’s Phase 1b clinical trial…

Read More Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShield single dose intranasal anthrax vaccine candidateContinue

Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
COVID-19 | Infectious Disease | Vaccine

Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials

On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…

Read More Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trialsContinue

MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine

MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations

On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…

Read More MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populationsContinue

COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
Biotechnology | COVID-19 | Medical Device | Therapeutics | Vaccine

COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration

On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…

Read More COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaborationContinue

Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
COVID-19 | Life Science History | Vaccine

Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow

On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…

Read More Vaxart signed Memorandum of Understanding with Attwill Medical Solutions SterilflowContinue

Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award
COVID-19 | Vaccine

Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award

On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…

Read More Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million awardContinue

Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Vaccine

Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research

On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…

Read More Government of Canada and provincial partners invested more than $109 mllion in COVID-19 researchContinue

Page navigation

Previous PagePrevious 1 … 48 49 50 51 52 … 75 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search